FMR CORP 13D and 13G filings for Lexicon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Purchase |
2024-11-08 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
FMR CORP | 49,867,042 13.794% |
11,179,919 (+28.90%) |
Filing |
| 2024-07-10 10:10 am Purchase |
2024-07-09 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
FMR CORP | 38,687,123 10.702% |
33,018,985 (+582.54%) |
Filing |
| 2022-02-09 09:22 am Sale |
2022-02-08 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
FMR CORP | 5,668,138 3.806% |
-2,629,962 (-31.69%) |
Filing |
| 2021-01-11 10:51 am Sale |
2021-01-08 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
FMR CORP | 8,298,100 5.864% |
-4,261,394 (-33.93%) |
Filing |